This playbook details six key steps for successful tech transfers with CDMO partners to reduce risks in drug manufacturing.
With contract development and manufacturing organizations (CDMOs) now manufacturing nearly half of global biologics—a figure expected to reach 56% by 2029—technology transfer capabilities have become a critical differentiator for successful partnerships and risk mitigation.
Download the playbook now for six essential steps for executing successful CDMO technology transfers, drawing from industry best practices and expert insights. Learn how strategic planning, standardized processes, and comprehensive gap assessments can accelerate time-to-market while maintaining quality standards and regulatory compliance.